Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30541745

FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Cancer Res
Publication date
2019 May 1
First author
Krauss AC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Krauss AC
      type
      Author
    2. name
      Gao X
      type
      Author
    3. name
      Li L
      type
      Author
    4. name
      Manning ML
      type
      Author
    5. name
      Patel P
      type
      Author
    6. name
      Fu W
      type
      Author
    7. name
      Janoria KG
      type
      Author
    8. name
      Gieser G
      type
      Author
    9. name
      Bateman DA
      type
      Author
    10. name
      Przepiorka D
      type
      Author
    11. name
      Shen YL
      type
      Author
    12. name
      Shord SS
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Krauss AC
      type
      Author
    2. name
      Gao X
      type
      Author
    3. name
      Li L
      type
      Author
    4. name
      Manning ML
      type
      Author
    5. name
      Patel P
      type
      Author
    6. name
      Fu W
      type
      Author
    7. name
      Janoria KG
      type
      Author
    8. name
      Gieser G
      type
      Author
    9. name
      Bateman DA
      type
      Author
    10. name
      Przepiorka D
      type
      Author
    11. name
      Shen YL
      type
      Author
    12. name
      Shord SS
      type
      Author
    bibliography ids
    1. nci-bib-2e2e55dfc9595963a775bb81
    book metadata
    content sha256
    18d20564748dcddba933aade4163a3b268ba52b9610790bcaafecec44a353415
    document type
    citation
    dois
    1. 10.1158/1078-0432.CCR-18-2990
    electronic publication date
    display
    2018 Dec 12
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:30541745
    immutable id
    pubmed:30541745@18d20564748dcddba933aade4163a3b268ba52b9610790bcaafecec44a353415
    journal
    abbreviation
    Clin Cancer Res
    issn electronic
    1557-3265
    issn print
    1078-0432
    issue
    9
    name
    Clinical cancer research : an official journal of the American Association for Cancer Research
    nlm unique id
    9502500
    pages
    2685-2690
    volume
    25
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      30541745
      provenance
      batch id
      438b2803888025c6cf56
      provider
      NCBI PubMed ESummary
      record sha256
      c851686b04dc1f08f142f5c3286fd1b06e4c8e3bc919873b6c72abf3d8d3c43c
      response sha256
      0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
      retrieved at
      2026-09-09T23:47:36.359220+00:00
      publication date
      display
      2019 May 1
      precision
      day
      year
      2019
      publication types
      1. Journal Article
      2. Multicenter Study
      3. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/30541745/
      title
      FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia.

      Preserved source evidence · Not medical advice